HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
| dc.contributor.author | Nyanhete, Tinashe E | |
| dc.contributor.author | Frisbee, Alyse L | |
| dc.contributor.author | Bradley, Todd | |
| dc.contributor.author | Faison, William J | |
| dc.contributor.author | Robins, Elizabeth | |
| dc.contributor.author | Payne, Tamika | |
| dc.contributor.author | Freel, Stephanie A | |
| dc.contributor.author | Sawant, Sheetal | |
| dc.contributor.author | Weinhold, Kent J | |
| dc.contributor.author | Wiehe, Kevin | |
| dc.contributor.author | Haynes, Barton F | |
| dc.contributor.author | Ferrari, Guido | |
| dc.contributor.author | Li, Qi-Jing | |
| dc.contributor.author | Moody, M Anthony | |
| dc.contributor.author | Tomaras, Georgia D | |
| dc.date.accessioned | 2020-12-01T15:11:11Z | |
| dc.date.available | 2020-12-01T15:11:11Z | |
| dc.date.issued | 2019-07-15 | |
| dc.date.updated | 2020-12-01T15:11:08Z | |
| dc.description.abstract | A paradigm shifting study demonstrated that induction of MHC class E and II-restricted CD8+ T cells was associated with the clearance of SIV infection in rhesus macaques. Another recent study highlighted the presence of HIV-1-specific class II-restricted CD8+ T cells in HIV-1 patients who naturally control infection (virus controllers; VCs). However, questions regarding class II-restricted CD8+ T cells ontogeny, distribution across different HIV-1 disease states and their role in viral control remain unclear. In this study, we investigated the distribution and anti-viral properties of HLA-DRB10701 and DQB10501 class II-restricted CD8+ T cells in different HIV-1 patient cohorts; and whether class II-restricted CD8+ T cells represent a unique T cell subset. We show that memory class II-restricted CD8+ T cell responses were more often detectable in VCs than in chronically infected patients, but not in healthy seronegative donors. We also demonstrate that VC CD8+ T cells inhibit virus replication in both a class I- and class II-dependent manner, and that in two VC patients the class II-restricted CD8+ T cells with an anti-viral gene signature expressed both CD4+ and CD8+ T cell lineage-specific genes. These data demonstrated that anti-viral memory class II-restricted CD8+ T cells with hybrid CD4+ and CD8+ features are present during natural HIV-1 infection. | |
| dc.identifier | 10.1038/s41598-019-46462-8 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Springer Science and Business Media LLC | |
| dc.relation.ispartof | Scientific reports | |
| dc.relation.isversionof | 10.1038/s41598-019-46462-8 | |
| dc.subject | CD4-Positive T-Lymphocytes | |
| dc.subject | CD8-Positive T-Lymphocytes | |
| dc.subject | Humans | |
| dc.subject | HIV-1 | |
| dc.subject | HIV Infections | |
| dc.subject | HIV Seropositivity | |
| dc.subject | Histocompatibility Antigens Class II | |
| dc.subject | Viral Load | |
| dc.subject | Virus Replication | |
| dc.subject | Adult | |
| dc.subject | Female | |
| dc.subject | Male | |
| dc.subject | HLA-DQ beta-Chains | |
| dc.subject | HLA-DRB1 Chains | |
| dc.title | HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Weinhold, Kent J|0000-0003-4876-6737 | |
| duke.contributor.orcid | Ferrari, Guido|0000-0001-7747-3349 | |
| duke.contributor.orcid | Li, Qi-Jing|0000-0002-0542-9784 | |
| duke.contributor.orcid | Moody, M Anthony|0000-0002-3890-5855 | |
| duke.contributor.orcid | Tomaras, Georgia D|0000-0001-8076-1931 | |
| pubs.begin-page | 10165 | |
| pubs.issue | 1 | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Duke Human Vaccine Institute | |
| pubs.organisational-group | Immunology | |
| pubs.organisational-group | Pediatrics, Infectious Diseases | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Pediatrics | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Staff | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | Surgery, Surgical Sciences | |
| pubs.organisational-group | Surgery | |
| pubs.organisational-group | Duke Global Health Institute | |
| pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
| pubs.organisational-group | University Institutes and Centers | |
| pubs.organisational-group | Institutes and Provost's Academic Units | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Molecular Genetics and Microbiology | |
| pubs.organisational-group | Duke Innovation & Entrepreneurship | |
| pubs.organisational-group | Initiatives | |
| pubs.publication-status | Published | |
| pubs.volume | 9 |
Files
Original bundle
- Name:
- HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.pdf
- Size:
- 4.48 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version